The results obtained from this study are significant because they demonstrate that chemotherapy drugs and PD-1/PD-L1-targeted inhibitors have different effects on the expression of PD-L1 and drug resistance-related proteins in breast cancer, particularly in tumors with varying immune cell populations. Here, CD274 is linked to breast cancer.